HALOZYME THERAPEUT earnings per share and revenue

RV7 earnings per share for the last quarter are 0.71 CHF whereas the estimation was 0.62 CHF which accounts for 15.07% surprise. Företagets omsättning för samma period uppgår till 176.71 M CHF trots den uppskattade siffran 180.19 M CHF. Estimated earnings per share for the next quarter are 0.68 CHF, and revenue is expected to reach 187.86 M CHF. Also watch annual changes over time to get a bigger picture of RV7 earnings per share and revenue dynamics.